Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection. - Test2 - elhamkhani - TriplyDB

Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection.

Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection.

http://www.wikidata.org/entity/Q37742680

about

Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection.

http://www.wikidata.org/entity/Q37742680

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chlamydial Type III Secretion ...... idarum Intravaginal Infection.

@en

Chlamydial Type III Secretion ...... idarum Intravaginal Infection.

@nl

type

label

Chlamydial Type III Secretion ...... idarum Intravaginal Infection.

@en

Chlamydial Type III Secretion ...... idarum Intravaginal Infection.

@nl

prefLabel

Chlamydial Type III Secretion ...... idarum Intravaginal Infection.

@en

Chlamydial Type III Secretion ...... idarum Intravaginal Infection.

@nl

P1433

Q37742680-FDBEB8B3-1869-4FC7-B589-D0B071B6EFDB

P1476

Q37742680-39746F6F-4BFE-4C48-93F3-9D286E3AA421

P2093

Q37742680-167A90F1-E2A1-4AC1-9713-D68ACF40FA55

Q37742680-1DECD34A-9183-4D67-AC5C-00B27233E247

Q37742680-3EAD613F-E9D8-45B8-8A5D-9E5CD368DD53

Q37742680-5732B1DF-D92C-40CD-B6F0-CD0916B3B6EB

Q37742680-57956983-4D9A-4810-BA7A-74930B7F7606

Q37742680-764012E9-CBAE-4B71-8B9E-239AA678D638

Q37742680-CEECD2FB-250D-4B5E-B582-C0C1DE0A82C4

P2860

Q37742680-0253F8E7-1CBB-422C-8704-5426AF0878B8

Q37742680-03E9DC58-801A-4354-ACFE-EA61293006C7

Q37742680-066F9E60-C148-4AB4-BEFB-1DDF8D580A19

Q37742680-0B6F698F-DA54-47BE-8746-04140C8C2531

Q37742680-0EC6B1AA-FB9B-4F7F-AE4F-2A43014BBC30

Q37742680-0ED063F6-9290-483B-8629-E96382DDEE45

Q37742680-1259540E-E172-4F66-801F-1E5E744F88C1

Q37742680-1BA1E87A-15B2-49ED-AFA8-6765DFC41810

Q37742680-1EA13FDA-6DFE-4B9D-9B79-D2AA8CEBD50B

Q37742680-226D7FBE-F3DD-4DEA-949F-5324D492F3CC

P304

Q37742680-40FA71C1-2765-4E5A-8636-3F490EF01BF6

P31

Q37742680-22BFE79D-56AB-468D-A880-0F052D5C8E03

P356

Q37742680-D0F9D20D-5C91-43B9-A23C-B84A5C2E4BD7

P407

Q37742680-602D07C3-EEC0-4D33-8576-F5DAAEA58771

P478

Q37742680-9523EFE5-BF24-4156-8F9F-D52A072A7A8B

P50

Q37742680-371888EB-4419-4664-AFF6-B156B45EEB33

Q37742680-40EDBD89-5891-453D-BDC8-624D3143E924

P577

Q37742680-B6F716D4-CEE3-423E-8506-81831E1344F4

P698

Q37742680-55E6A261-5292-4562-8CB9-7550088D500F

P932

Q37742680-D0C29C80-7316-4CBE-B6CD-44342C685DA1

P356

P1433

BioMed Research International

P1476

Chlamydial Type III Secretion ...... ridarum Intravaginal Infection

@en

P2093

Alexander L Gintsburg

http://www.w3.org/2001/XMLSchema#string

Amir I Tukhvatulin

http://www.w3.org/2001/XMLSchema#string

Boris S Naroditsky

http://www.w3.org/2001/XMLSchema#string

Denis Y Logunov

http://www.w3.org/2001/XMLSchema#string

Dmitrii N Shcherbinin

http://www.w3.org/2001/XMLSchema#string

Maxim M Shmarov

http://www.w3.org/2001/XMLSchema#string

Naylia A Zigangirova

http://www.w3.org/2001/XMLSchema#string

P2860

Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens

A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge

Bioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatis

Development of adenoviral vector-based mucosal vaccine against influenza.

Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.

Role of gamma interferon in controlling murine chlamydial genital tract infection.

Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.

Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.

Immunity to murine chlamydial genital infection.

Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.

P304

3865802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/3865802

http://www.w3.org/2001/XMLSchema#string

P407

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Ekaterina A Koroleva

P577

2017-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28459057

http://www.w3.org/2001/XMLSchema#string

P932

5385227

http://www.w3.org/2001/XMLSchema#string